title: Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.
abstract: We hereby describe the satisfactory evolution of rituximab treatment in two patients with Wegener's granulomatosis (WG). Rituximab was indicated for refractoriness to standard treatment in one case and life-threatening myelotoxicity due to alkylating agents in the other. A brief review of previous experience with the use of rituximab in the treatment of WG is presented.
authors: Internal Medicine Service, Hospital de Sabadell, Corporació Parc Taulí, Universitat Autònoma de Barcelona (UAB), Spain.
authors: Joaquim
authors: J
authors: Oristrell
authors: Guillermina
authors: G
authors: Bejarano
authors: Rosa
authors: R
authors: Jordana
authors: Manuel
authors: M
authors: Monteagudo
authors: Begoña
authors: B
authors: Marí
authors: Arnau
authors: A
authors: Casanovas
authors: Carles
authors: C
authors: Tolosa